Tag Archivio per: Antitrust
https://www.pharmadoc.it/wp-content/uploads/2022/11/Antitrust_brevetti.png
1080
1558
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2022-11-07 12:26:402022-11-07 12:26:40Brevetti divisionali: il caso TEVA in Europa
https://www.pharmadoc.it/wp-content/uploads/2021/09/IN_LABEL_OFF_LABEL_DRUG.jpg
845
1299
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2021-09-07 15:13:362021-09-07 15:50:29Bevacizumab e dintorni
https://www.pharmadoc.it/wp-content/uploads/2019/07/Antitrus-law-3.png
597
834
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-07-17 15:58:162019-07-17 15:58:16Il lunedì nero di Novartis e Roche: la doppia pronuncia del consiglio di stato sul caso LUCENTIS-AVASTIN
https://www.pharmadoc.it/wp-content/uploads/2019/02/shutterstock_767639497.jpg
1067
1600
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-02-26 14:40:392020-10-15 12:40:13Patent Linkage e CPC: novitá di rilievo per generici e biosimilari, ma non per l’Italia!